CD69 blocking peptide product blog
Tags: Blocking Peptide; CD69; CD69 blocking peptide;
The CD69 cd69 (Catalog #MBS9230885) is a Blocking Peptide and is intended for research purposes only. The product is available for immediate purchase.The CD69 cd69 product has the following accession number(s) (GI #4502681) (NCBI Accession #NP_001772.1) (Uniprot Accession #Q07108). Researchers may be interested in using Bioinformatics databases such as those available at The National Center for Biotechnology Information (NCBI) website for more information about accession numbers and the proteins they represent. Even researchers unfamiliar with bioinformatics databases will find the NCBI databases to be quite user friendly and useful.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Involved in lymphocyte proliferation and functions as a signal transmitting receptor in lymphocytes, natural killer (NK) cells, and platelets.
Cellular Location: Membrane; Single-pass type II membrane protein. Tissue Location: Expressed on the surface of activated T-cells, B-cells, natural killer cells, neutrophils, eosinophils, epidermal Langerhans cells and platelets. CD69 also interacts with the following gene(s): CD4, CD8A, CSF2, ICAM1, IL2, LCK, NCAM1, S1PR1, STAT5A, STAT5B. Arthritis, Heart Diseases, Hematologic Diseases, Immune System Diseases, Inflammation, Kidney Diseases, Liver Diseases, Lung Diseases, Necrosis, Neoplasms, Experimental are some of the diseases may be linked to CD69 Blocking Peptide (Center). Blood, Bone Marrow, Intestine, Kidney, Liver, Lung, Lymph Node, Spleen, Thymus, Vascular tissues are correlated with this protein.